ARCHIVES

As For-Profits Provide Phase I Studies, NCI Seeks to Look Deeper and Learn More

This article is from The Cancer Letter archive.

Vol. 38 No. 14 | April 6, 2012

Download PDF Visit The Full Archive

Related Articles

Retraction Based On Data Given To Duke Last November, But Apparently Disregarded

October 29, 2010

Congress Signals Willingness to Break With Administration on NIH Funding.

March 24, 2006

FDA Committee Approves NDA for Mitxantrone

March 21, 1986

More Control Project Plans, Future RPs Listed

November 15, 1974

Diet & Nutrition, Carcinogenesis, Virus, Tobacco Committees Proposed For Elimination

May 6, 1977

High Response Rate of Hairy Cell Leukemia Patients to Immunotoxin Treatment In Phase I

April 27, 2001